SECURE-PCI-话题@MedSci

#SECURE-PCI#

7篇内容 | 702人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702892, encodeId=f3461e02892ae, content=<a href='/topic/show?id=c5d51610045' target=_blank style='color:#2F92EE;'>#SECURE-PCI#</a>, objectTitle=JAMA：急性冠状动脉综合征患者围术期负荷剂量他汀不能减少1年心血管事件（SECURE-PCI 研究）, objectType=article, longId=191489, objectId=c75c19148929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c75c19148929, replyNumber=0, likeNumber=33, createdTime=2020-11-18, rootId=0, userName=xuruicheng, userId=cc7e30440554, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c75c19148929, moduleTitle=JAMA：急性冠状动脉综合征患者围术期负荷剂量他汀不能减少1年心血管事件（SECURE-PCI 研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c75c19148929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702890, encodeId=bf681e02890d5, content=<a href='/topic/show?id=c5d51610045' target=_blank style='color:#2F92EE;'>#SECURE-PCI#</a>, objectTitle=名家观点系列（四）：SECURE-PCI及相关研究解读与启示, objectType=article, longId=138364, objectId=e4ce1383647b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4ce1383647b, replyNumber=0, likeNumber=51, createdTime=2018-09-12, rootId=0, userName=xuruicheng, userId=cc7e30440554, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4ce1383647b, moduleTitle=名家观点系列（四）：SECURE-PCI及相关研究解读与启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4ce1383647b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702891, encodeId=17231e02891b4, content=<a href='/topic/show?id=c5d51610045' target=_blank style='color:#2F92EE;'>#SECURE-PCI#</a>, objectTitle=从统计学视角解读SECURE-PCI 研究：负荷剂量阿托伐他汀获益仍是假设, objectType=article, longId=146072, objectId=365d1460e281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=365d1460e281, replyNumber=0, likeNumber=31, createdTime=2018-10-14, rootId=0, userName=xuruicheng, userId=cc7e30440554, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=365d1460e281, moduleTitle=从统计学视角解读SECURE-PCI 研究：负荷剂量阿托伐他汀获益仍是假设, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=365d1460e281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702889, encodeId=7ada1e0288980, content=<a href='/topic/show?id=c5d51610045' target=_blank style='color:#2F92EE;'>#SECURE-PCI#</a>, objectTitle=名家观点系列（三）：SECURE-PCI及相关研究解读与启示, objectType=article, longId=138362, objectId=8f5113836242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f5113836242, replyNumber=0, likeNumber=45, createdTime=2018-12-05, rootId=0, userName=xuruicheng, userId=cc7e30440554, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f5113836242, moduleTitle=名家观点系列（三）：SECURE-PCI及相关研究解读与启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f5113836242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702887, encodeId=f5ad1e0288733, content=<a href='/topic/show?id=c5d51610045' target=_blank style='color:#2F92EE;'>#SECURE-PCI#</a>, objectTitle=SECURE-PCI及相关研究解读与启示（一）, objectType=article, longId=138030, objectId=175c13803070, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175c13803070, replyNumber=0, likeNumber=45, createdTime=2018-12-21, rootId=0, userName=xuruicheng, userId=cc7e30440554, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175c13803070, moduleTitle=SECURE-PCI及相关研究解读与启示（一）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=175c13803070)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702888, encodeId=e39d1e028886c, content=<a href='/topic/show?id=c5d51610045' target=_blank style='color:#2F92EE;'>#SECURE-PCI#</a>, objectTitle=SECURE-PCI及相关研究解读与启示（二）, objectType=article, longId=138031, objectId=dcd413803163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcd413803163, replyNumber=0, likeNumber=46, createdTime=2019-04-15, rootId=0, userName=xuruicheng, userId=cc7e30440554, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcd413803163, moduleTitle=SECURE-PCI及相关研究解读与启示（二）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcd413803163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702886, encodeId=f9731e0288667, content=<a href='/topic/show?id=c5d51610045' target=_blank style='color:#2F92EE;'>#SECURE-PCI#</a>, objectTitle=JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI, objectType=article, longId=132152, objectId=afd513215299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afd513215299, replyNumber=0, likeNumber=35, createdTime=2018-04-22, rootId=0, userName=xuruicheng, userId=cc7e30440554, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afd513215299, moduleTitle=JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afd513215299)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SECURE-PCI

2020-05-29

xuruicheng (审核中...)

前往app查看评论内容

#SECURE-PCI#

JAMA：急性冠状动脉综合征患者围术期负荷剂量他汀不能减少1年心血管事件（SECURE-PCI 研究）

2020-11-18

xuruicheng (审核中...)

前往app查看评论内容

#SECURE-PCI#

名家观点系列（四）：SECURE-PCI及相关研究解读与启示

2018-09-12

xuruicheng (审核中...)

前往app查看评论内容

#SECURE-PCI#

从统计学视角解读SECURE-PCI 研究：负荷剂量阿托伐他汀获益仍是假设

2018-10-14

xuruicheng (审核中...)

前往app查看评论内容

#SECURE-PCI#

名家观点系列（三）：SECURE-PCI及相关研究解读与启示

2018-12-05

xuruicheng (审核中...)

前往app查看评论内容

#SECURE-PCI#

SECURE-PCI及相关研究解读与启示（一）

2018-12-21

xuruicheng (审核中...)

前往app查看评论内容

#SECURE-PCI#

SECURE-PCI及相关研究解读与启示（二）

2019-04-15

xuruicheng (审核中...)

前往app查看评论内容

#SECURE-PCI#

JAMA：PCI围术期患者需要应用负荷剂量他汀吗？从ARMYDA-ACS到ALPACS与ISCAP,再到SECURE-PCI

2018-04-22

科室
- - 订阅+
  - 更多科室
工具
服务